Epizyme, Inc.
Hedge Funds Holdings
Last updated:
Epizyme, Inc.‘s stocks are currently a part of 115 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 143.93M shares of Epizyme, Inc.. Compared to the previous quarter, the number grew by 69.64% or 59.08M shares more. As for the holding position changes, 47.83% (55) of current hedge fund investors increased the number of shares held, 20% (23) of current holders sold a part of the shares held, and 30.43% (35) closed the holdings completely. 21 hedge funds are new holders of Epizyme, Inc. stock in Q1 2022, it is 18.26% of total holders.
Hedge funds holding Epizyme (Q2 2017 – Q1 2022)
| Q2 2017 | 108 |
|---|---|
| Q3 2017 | 105 |
| Q4 2017 | 101 |
| Q1 2018 | 108 |
| Q2 2018 | 107 |
| Q3 2018 | 103 |
| Q4 2018 | 101 |
| Q1 2019 | 117 |
| Q2 2019 | 129 |
| Q3 2019 | 108 |
| Q4 2019 | 130 |
| Q1 2020 | 139 |
| Q2 2020 | 156 |
| Q3 2020 | 146 |
| Q4 2020 | 135 |
| Q1 2021 | 136 |
| Q2 2021 | 125 |
| Q3 2021 | 113 |
| Q4 2021 | 131 |
| Q1 2022 | 115 |
Hedge funds changes in Epizyme positions (Q2 2017 – Q1 2022)
| Q2 2017 | 26 | 40 | 19 | 13 | 10 |
|---|---|---|---|---|---|
| Q3 2017 | 15 | 48 | 24 | 18 | 0 |
| Q4 2017 | 15 | 40 | 27 | 18 | 1 |
| Q1 2018 | 22 | 38 | 30 | 13 | 5 |
| Q2 2018 | 18 | 47 | 29 | 19 | -6 |
| Q3 2018 | 16 | 35 | 30 | 20 | 2 |
| Q4 2018 | 14 | 55 | 19 | 16 | -3 |
| Q1 2019 | 35 | 40 | 28 | 19 | -5 |
| Q2 2019 | 36 | 52 | 26 | 20 | -5 |
| Q3 2019 | 10 | 32 | 42 | 31 | -7 |
| Q4 2019 | 40 | 38 | 39 | 17 | -4 |
| Q1 2020 | 31 | 50 | 47 | 20 | -9 |
| Q2 2020 | 39 | 68 | 35 | 21 | -7 |
| Q3 2020 | 26 | 48 | 43 | 33 | -4 |
| Q4 2020 | 20 | 47 | 43 | 33 | -8 |
| Q1 2021 | 19 | 51 | 40 | 15 | 11 |
| Q2 2021 | 16 | 45 | 37 | 26 | 1 |
| Q3 2021 | 9 | 37 | 37 | 21 | 9 |
| Q4 2021 | 39 | 38 | 36 | 21 | -3 |
| Q1 2022 | 21 | 55 | 23 | 35 | -19 |
Hedge funds changes in Epizyme stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 2,586,000 | 2,243,000 |
|---|---|---|
| Q3 2017 | 5,199,000 | 3,418,000 |
| Q4 2017 | 2,267,000 | 1,159,000 |
| Q1 2018 | 1,174,000 | 947,000 |
| Q2 2018 | 754,000 | 739,000 |
| Q3 2018 | 475,000 | 560,000 |
| Q4 2018 | 216,000 | 216,000 |
| Q1 2019 | 266,000 | 1,315,000 |
| Q2 2019 | 687,000 | 2,105,000 |
| Q3 2019 | 2,723,000 | 139,000 |
| Q4 2019 | 83,608,000 | 7,161,000 |
| Q1 2020 | 47,874,000 | 4,845,000 |
| Q2 2020 | 59,229,000 | 3,826,000 |
| Q3 2020 | 30,397,000 | 2,100,000 |
| Q4 2020 | 28,936,000 | 2,733,000 |
| Q1 2021 | 22,299,000 | 2,174,000 |
| Q2 2021 | 23,495,000 | 2,628,000 |
| Q3 2021 | 13,870,000 | 1,489,000 |
| Q4 2021 | 6,448,000 | 1,081,000 |
| Q1 2022 | 3,869,000 | 257,000 |